<section class="slide" data-slide-id="S46">

  <!-- HEADER -->
  <div style="margin-bottom: 1.6vw;">
    <div class="label-gold" style="margin-bottom: 0.55vw;">CONSENSOS (EAS / NLA / ACC) — DIAGNÓSTICO E MANEJO INICIAL</div>
    <h2 style="margin-bottom: 0.55vw;">Confirmando SAMS: algoritmo curto antes de abandonar estatina</h2>
    <div class="lead" style="max-width: 92%;">
      O objetivo é evitar o erro mais comum: <b>parar definitivo</b> sem testar causalidade.
    </div>
  </div>

  <!-- LAYOUT -->
  <div style="display: grid; grid-template-columns: 1.55fr 1fr; gap: 2.0vw; flex-grow: 1; align-items: start;">

    <!-- LEFT: FLOW -->
    <div style="display:flex; flex-direction:column; gap: 1.15vw;">

      <div class="card" style="padding: 1.35vw;">
        <div class="small-title">Passo a passo (3 blocos)</div>

        <div style="margin-top: 0.95vw; display:grid; gap: 0.95vw;">

          <div style="border: 1px solid var(--border); border-radius: 0.95vw; padding: 1.05vw; background: rgba(var(--navy-rgb),0.02);">
            <div style="display:flex; align-items:baseline; justify-content:space-between; gap: 0.9vw;">
              <div style="font-size: 1.15vw; font-weight: 900; color: var(--navy);">1) Fenótipo + causas alternativas</div>
              <span class="chip chip--muted">triagem</span>
            </div>
            <div style="margin-top: 0.55vw; display:grid; gap: 0.45vw; font-size: 1.03vw; line-height: 1.4; color: var(--text);">
              <div class="bulletRow"><span class="iconCircle">•</span><span><b>Temporalidade</b> + padrão (simétrico, proximal)</span></div>
              <div class="bulletRow"><span class="iconCircle">•</span><span>Checar: <b>hipotireoidismo</b>, interações (CYP), álcool/exercício, def. Vit D</span></div>
            </div>
          </div>

          <div style="border: 1px solid rgba(var(--gold-rgb),0.35); border-radius: 0.95vw; padding: 1.05vw; background: rgba(var(--gold-rgb),0.08);">
            <div style="display:flex; align-items:baseline; justify-content:space-between; gap: 0.9vw;">
              <div style="font-size: 1.15vw; font-weight: 900; color: var(--navy);">2) Teste de causalidade (pragmático)</div>
              <span class="chip chip--gold">dechallenge/rechallenge</span>
            </div>
            <div style="margin-top: 0.55vw; display:grid; gap: 0.45vw; font-size: 1.03vw; line-height: 1.4; color: var(--text);">
              <div class="bulletRow"><span class="iconCircle iconCircle--gold">A</span><span><b>Dechallenge:</b> suspender 2–4 semanas (se seguro) e reavaliar</span></div>
              <div class="bulletRow"><span class="iconCircle iconCircle--gold">B</span><span><b>Rechallenge:</b> outra estatina / dose menor / esquema alternado</span></div>
            </div>

            <div class="note" style="margin-top: 0.75vw; border-left-color: var(--navy); background: rgba(var(--navy-rgb),0.05);">
              <p style="margin:0; font-size: 0.98vw; line-height: 1.4; color: var(--navy);">
                <b>Regra NLA:</b> para chamar de “intolerância”, testar <b>≥ 2 estatinas</b> (uma na menor dose aprovada).
              </p>
            </div>
          </div>

          <div style="border: 1px solid rgba(var(--teal-rgb),0.28); border-radius: 0.95vw; padding: 1.05vw; background: rgba(var(--teal-rgb),0.07);">
            <div style="display:flex; align-items:baseline; justify-content:space-between; gap: 0.9vw;">
              <div style="font-size: 1.15vw; font-weight: 900; color: var(--navy);">3) Classificar e agir</div>
              <span class="chip chip--teal">plano</span>
            </div>
            <div style="margin-top: 0.55vw; display:grid; gap: 0.45vw; font-size: 1.03vw; line-height: 1.4; color: var(--text);">
              <div class="bulletRow"><span class="iconCircle iconCircle--teal">✓</span><span><b>Parcial:</b> manter <i>maior dose tolerada</i> + adicionar não‑estatinas</span></div>
              <div class="bulletRow"><span class="iconCircle iconCircle--teal">✓</span><span><b>Completa (rara):</b> não‑estatinas tornam‑se o eixo</span></div>
            </div>
          </div>

        </div>
      </div>

    </div>

    <!-- RIGHT: SAFETY + SCRIPT -->
    <div style="display:flex; flex-direction:column; gap: 1.15vw;">

      <div class="card bg-navy" style="padding: 1.35vw; border: 1px solid rgba(255,255,255,0.14);">
        <div style="font-size: 0.82vw; color: rgba(255,255,255,0.75); text-transform: uppercase; letter-spacing: 0.10em; font-weight: 900;">Red flags (não insistir)</div>
        <div style="margin-top: 0.95vw; display:grid; gap: 0.75vw; font-size: 1.05vw; line-height: 1.5; color: rgba(255,255,255,0.90);">
          <div class="bulletRow"><span class="iconCircle iconCircle--danger">!</span><span><b>CK muito elevada</b> / rabdomiólise / sintomas sistêmicos</span></div>
          <div class="bulletRow"><span class="iconCircle iconCircle--danger">!</span><span><b>Fraqueza progressiva</b> (suspeitar miopatia imunomediada)</span></div>
          <div class="bulletRow"><span class="iconCircle iconCircle--danger">!</span><span>Interação grave ou insuf. renal/hepática descompensada</span></div>
        </div>
      </div>

      <div class="card" style="padding: 1.35vw;">
        <div class="small-title">Script anti‑nocebo (30s)</div>
        <p style="margin: 0.85vw 0 0 0; font-family: var(--font-serif); font-size: 1.22vw; line-height: 1.45; color: var(--navy);">
          “Dor muscular é comum. Em testes N‑of‑1, placebo e estatina geram sintomas parecidos na maioria. Vamos testar com segurança e manter o que protege seu coração.”
        </p>
      </div>

    </div>

  </div>

  <!-- FOOTER -->
  <div style="margin-top: auto; padding-top: 1vw; border-top: 1px solid var(--border);">
    <p class="ref" style="margin: 0;">
      <b>Fontes:</b> Stroes ES et al. EAS Consensus. <i>Eur Heart J</i> 2015 &nbsp;|&nbsp; Cheeley MK et al. NLA Statement. <i>J Clin Lipidol</i> 2022 &nbsp;|&nbsp; Newman CB et al. AHA Statement. <i>ATVB</i> 2019.
    </p>
  </div>

</section>
